Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,353 public trials 3,272 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, not recruiting

Testing Nivolumab and Ipilimumab With Short-Course Radiation in Locally Advanced Rectal Cancer

NCT04751370

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +11 more
Locations
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 213 locations
View Trial Details
Active, not recruiting

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

NCT04704661

Conditions
Advanced Breast Carcinoma, Advanced Colon Carcinoma, Advanced Colorectal Carcinoma, +80 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View all 23 locations
View Trial Details
Active, not recruiting

First-line Regimen With QL1706 Plus Chemo ± Bev in PDAC Patients

NCT06313970

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Fudan University Shanghai Cancer Center Shanghai, China
  • Huadong Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
  • The Second Affiliated Hospital of Naval Medical University (Shanghai Changzheng Hospital) Shanghai, China
View Trial Details
Active, not recruiting

Durvalumab or Placebo in Combination With Gemcitabine/Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer (TOPAZ-1)

NCT03875235

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Digestive System Diseases, +3 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Fort Myers, Florida, United States
View all 126 locations
View Trial Details
Active, not recruiting

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

NCT02568267

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +91 more
Locations
  • Dignity Health St Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope Duarte - Comprehensive Cancer Center, Investigational Drug Services Duarte, California, United States
View all 120 locations
View Trial Details
Active, not recruiting

S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

NCT06188702

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Bronchial Neoplasms, +12 more
Locations
  • Lake Mary Cancer Center - Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
View all 20 locations
View Trial Details
Active, not recruiting

A Study to Evaluate INCB186748 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

NCT06818812

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • UCLA Healthcare Hematology-Oncology Santa Monica, California, United States
  • Sarah Cannon Research Institue At Healthone Denver, Colorado, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View Trial Details

Related conditions